These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 608522)

  • 21. Induction and cross-species activity of rat fibroblast-derived interferon.
    Abreu SL; Cannella MS; Hanke J
    Microbios; 1981; 30(121-122):181-90. PubMed ID: 6171704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bypassing the "species barrier" with carbohydrate-altered interferon from leukocytes.
    Carter WA
    Cancer Res; 1979 Sep; 39(9):3796-8. PubMed ID: 476703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients.
    Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E
    Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipyridamole is an interferon inducer.
    Galabov AS; Mastikova M
    Acta Virol; 1982 May; 26(3):137-47. PubMed ID: 6181668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon and spontaneous cytotoxicity in man. IV. Evidence for interferon as the factor in human interferon preparations causing enhancement of spontaneous cytotoxicity.
    Einhorn S
    J Clin Lab Immunol; 1980 Jan; 3(1):35-8. PubMed ID: 6155470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of human lymphoblastoid interferon.
    Strander H; Mogensen KE; Cantell K
    J Clin Microbiol; 1975 Jan; 1(1):116-7. PubMed ID: 170301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon: pharmacokinetics and toxicity.
    Scott GM
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in sialic acid content of human interferons.
    Morser J; Kabayo JP; Hutchinson DW
    J Gen Virol; 1978 Oct; 41(1):175-8. PubMed ID: 702115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of 125I-labelled human alpha interferon to human lymphoid cells.
    Mogensen KE; Bandu MT; Vignaux F; Aguet M; Gressner I
    Int J Cancer; 1981 Nov; 28(5):575-82. PubMed ID: 6171531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The classification and biological functions of the interferons. A review.
    Finter NB
    J Hepatol; 1986; 3 Suppl 2():S157-60. PubMed ID: 2439570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of two species of human lymphoblastoid (Namalva) cell-derived interferon that differ in rates of clearance, size, and cell specificity.
    Traub A; Feinstein S; Grosfeld H; Payess B; Lazar A; Reuveny S; Mizrahi A
    J Interferon Res; 1981; 1(4):571-9. PubMed ID: 6180089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon therapy for neoplastic diseases in man in vitro and in vivo studies.
    Einhorn S; Strander H
    Adv Exp Med Biol; 1978; 110():159-74. PubMed ID: 727040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferons and their antitumor properties.
    Platanias LC
    J Interferon Cytokine Res; 2013 Apr; 33(4):143-4. PubMed ID: 23570379
    [No Abstract]   [Full Text] [Related]  

  • 35. Production, purification and clinical application of human fibroblast interferon.
    Carter WA; Horoszewicz JS
    Pharmacol Ther; 1980; 8(2):359-77. PubMed ID: 6155675
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan.
    Kataoka T; Sakurai Y; Ida N; Kobayashi S
    Cancer Treat Rev; 1980 Dec; 7(4):253-6. PubMed ID: 6163536
    [No Abstract]   [Full Text] [Related]  

  • 37. Which will be the most useful interferon?
    Bocci V
    Ric Clin Lab; 1981; 11(1):27-32. PubMed ID: 6164090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino terminal sequence of the major component of human lymphoblastoid interferon.
    Zoon KC; Smith ME; Bridgen PJ; Anfinsen CB; Hunkapiller MW; Hood LE
    Science; 1980 Feb; 207(4430):527-8. PubMed ID: 7352260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon therapy: pharmacokinetic and pharmacological aspects.
    Billiau A
    Arch Virol; 1981; 67(2):121-33. PubMed ID: 6163417
    [No Abstract]   [Full Text] [Related]  

  • 40. Is fibroblast interferon antigenic for man?
    Tyrell DA
    Nature; 1981 Feb; 289(5797):446. PubMed ID: 6162103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.